[Ip-health] IGWG II: Limitation on Diseases

[Judit Rius Sanjuan]

We have been informed that yesterday night one of the drafting group
agreed to eliminate the footnote 1 included in the Secretariat Draft
Global Strategy and Plan of Action.

These are very good news because the footnote 1 included a unjustifiable
limitation by listing the diseases that will be the focus of this global
strategy and plan of action:

Footnote eliminated: "The Commission=92s definitions of Type I, Type II
and Type III diseases, and the specific diseases on which this draft
strategy focuses, are as follows: Type I diseases are incident in both
rich and poor countries, with large numbers of vulnerable populations in
each. The strategy will focus on the following Type I diseases,
increasingly prevalent in developing countries: diabetes, cardiovascular
disease and cancer. Type II diseases are incident in both rich and poor
countries, but with a substantial proportion of the cases in poor
countries. For the purposes of the strategy, the focus is on HIV/AIDS
and tuberculosis. Type III diseases are those that are overwhelmingly or
exclusively incident in developing countries. For the purposes of the
strategy, the focus is on the nine neglected infectious diseases that
disproportionately affect poor and marginalized populations prioritized
by the UNICEF/UNDP/World Bank/WHO Special Programme for Research and
Training in Tropical Diseases: Chagas disease, dengue and dengue
haemorrhagic fever, leishmaniasis, leprosy, lymphatic filariasis,
malaria, onchocerciasis, schistosomiasis and human African
trypanosomiasis."

--
Judit Rius Sanjuan
Attorney
judit.rius@keionline.org

Knowledge Ecology International (KEI)
www.keionline.org / www.cptech.org
1621 Connecticut Ave, NW, Suite 500 Washington, DC 20009 USA
Tel.: +1.202.332.2670, Ext 18  Fax: +1.202.332.2673